Fact CheckerSign in

NCT07294898CompletedPhase 1

A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Effect of a Low-Fat Meal and Evening Dosing on the Pharmacokinetics of KAI-7535 in Healthy Participants Living With Obesity or Overweight

Source: ClinicalTrials.gov · Last updated 29 Jan 2026

Brief summary (registry, in English)

The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
18 (actual)
First submitted
8 Dec 2025
Start date
15 Dec 2025
Primary completion date
26 Jan 2026
Lead sponsor
Kailera
Diseases
Obesity
NCT number
NCT07294898

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 18
  • From 15 Dec 2025 to the primary completion date, 26 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known hypersensitivity to study treatment or any study treatment ingredients.
  • History or presence of CS cardiovascular, pulmonary, hepatic, renal, hematological, GI, endocrine, immunologic, dermatologic, psychiatric, or neurological disease/disorder, including any acute illness, within the past 3 months.
    • Note: Additional inclusion/exclusion criteria may apply, per protocol.

Who the study is looking for

  • Body mass index (BMI) ≥25.0 and ≤40.0 kg/m\^2.
  • Medically healthy, as determined by prestudy medical history, and without clinically significant (CS) abnormalities.

Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Anaheim Clinical Trials
Coordinator of this site? Confirm its status
AnaheimUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.